Sort   by:  
 Page size 
EIF4A1 and cofactors EIF4B and EIF4H have been well characterised in cancers, including B cell malignancies, for their ability to promote the translation of oncogenes with structured 5’ untranslated regions. However, very little is known of their roles in non-malignant cells. Using mouse models to d...
ORGANISM(S): Mus musculus (Mouse) 
2023-11-09 | PXD046710 | Pride
Oncogenic translational programmes are an emerging hallmark of cancer and often driven by dysregulation of signaling pathways including KRAS and mTORC that converge on the eukaryotic translation initiation (eIF) 4F complex. Altered eIF4F activity promotes translation of oncogene mRNAs that typically...
ORGANISM(S): Homo sapiens (Human) 
2023-01-17 | PXD034343 | Pride
As the most life-threatening subtype of pediatric medulloblastoma (MB), MYC-amplified Group 3 (G3) MB lacks effective and selective therapeutics. We tried to indirectly target MYC (oncogenic driver and cancer-dependent molecule) production via inhibiting translational machinery. Through multiple dat...
ORGANISM(S): Homo Sapiens 
2020-10-15 | PXD022014 |
eIF4A1 enhances LARP1-mediated translational repression during mTORC1 inhibition
Authentication of Hippuristanol-eIF4A1 Target Engagement Facilitates Identification of eIF4A1 Helicase Dependencies within 5’ Leader Regions
EIF4A1 is essential in B cells by promoting activation-induced translation
Identification of eIF4A1-binding RNAs in human prostate cancer cell line DU145
Transcriptional profiling of mouse small intestinal tissue with Eif4a1/4a2 mutation
Sort   by:  
 Page size